Primary malignant melanoma of the vagina in Bangladesh: Report of a case series and review of the literature

2^nd Global Summit on Oncology & Cancer

March 12-14, 2018 Singapore

Shahana Pervin

National Institute of Cancer Research & Hospital, Bangladesh

Keynote: J Cancer Sci Ther

Abstract :

Objective: This study describes the characteristics of patients with primary malignant melanoma of the vagina and their treatment at National Institute of Cancer Research and Hospital in Dhaka, Bangladesh, from February 2013-January 2015. Materials & Methods: Eight patients with primary malignant melanoma of the vagina were identified. Medical records were reviewed for demographic information, treatment and outcomes. This investigation was approved by the Ethics Committee of the National Institute of Cancer Research and Hospital. Results: The median age was 48 years (Range: 35-65 years) and most patients were premenopausal. Seven of the eight patients presented with International Federation of Gynecology and Obstetrics (FIGO) stage-2. Five patients had disease confined mainly to the upper and middle thirds of the vagina. One patient was diagnosed with stage-4 disease. In two patients, cervical metastases were present. Almost all patients received radiotherapy. Two patients with stage-2 disease developed local recurrences within eighteen months and one patient with stage-4 disease died ten months after diagnosis. Conclusion: Primary malignant melanomas of the vagina are uncommon, highly aggressive tumors that are associated with poor overall survival. Surgery is the mainstay of treatment. Nearly 80% of vaginal melanomas will recur. Overall, 5 years survival ranges from 5% to 25%. The size of the tumor (>than 3 cm) and the presence of lymphadenopathy at diagnosis worsen the overall survival.

Biography :

Shahana Pervin is a surgeon at the National Institute of Cancer Research & Hospital, Bangladesh.
Email:shahana.pervin@yahoo.com